These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 33353986)

  • 21. Survey of Machine Learning Techniques in Drug Discovery.
    Stephenson N; Shane E; Chase J; Rowland J; Ries D; Justice N; Zhang J; Chan L; Cao R
    Curr Drug Metab; 2019; 20(3):185-193. PubMed ID: 30124147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The European Lead Factory: An updated HTS compound library for innovative drug discovery.
    van Vlijmen H; Ortholand JY; Li VM; de Vlieger JSB
    Drug Discov Today; 2021 Oct; 26(10):2406-2413. PubMed ID: 33892142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural products as catalysts for innovation: a pharmaceutical industry perspective.
    Schmitt EK; Moore CM; Krastel P; Petersen F
    Curr Opin Chem Biol; 2011 Aug; 15(4):497-504. PubMed ID: 21684800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of deep learning for the analysis of medical data.
    Jang HJ; Cho KO
    Arch Pharm Res; 2019 Jun; 42(6):492-504. PubMed ID: 31140082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep Learning in Virtual Screening: Recent Applications and Developments.
    Kimber TB; Chen Y; Volkamer A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of novel IVD assays: a manufacturer's perspective.
    Metcalfe TA
    Scand J Clin Lab Invest Suppl; 2010; 242():23-6. PubMed ID: 20515272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An analysis of original research contributions toward FDA-approved drugs.
    Patridge EV; Gareiss PC; Kinch MS; Hoyer DW
    Drug Discov Today; 2015 Oct; 20(10):1182-7. PubMed ID: 26113307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Have microfluidics delivered for drug discovery?
    Chandrasekaran A; Abduljawad M; Moraes C
    Expert Opin Drug Discov; 2016 Aug; 11(8):745-8. PubMed ID: 27266956
    [No Abstract]   [Full Text] [Related]  

  • 30. MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning.
    Buterez D; Janet JP; Kiddle SJ; Liò P
    J Chem Inf Model; 2023 May; 63(9):2667-2678. PubMed ID: 37058588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragment-based approaches in drug discovery and chemical biology.
    Scott DE; Coyne AG; Hudson SA; Abell C
    Biochemistry; 2012 Jun; 51(25):4990-5003. PubMed ID: 22697260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organs-on-chips at the frontiers of drug discovery.
    Esch EW; Bahinski A; Huh D
    Nat Rev Drug Discov; 2015 Apr; 14(4):248-60. PubMed ID: 25792263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies.
    Donato MT; Gómez-Lechón MJ; Tolosa L
    Expert Opin Drug Discov; 2017 Feb; 12(2):201-211. PubMed ID: 27936962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-content image generation for drug discovery using generative adversarial networks.
    Hussain S; Anees A; Das A; Nguyen BP; Marzuki M; Lin S; Wright G; Singhal A
    Neural Netw; 2020 Dec; 132():353-363. PubMed ID: 32977280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Data-analysis strategies for image-based cell profiling.
    Caicedo JC; Cooper S; Heigwer F; Warchal S; Qiu P; Molnar C; Vasilevich AS; Barry JD; Bansal HS; Kraus O; Wawer M; Paavolainen L; Herrmann MD; Rohban M; Hung J; Hennig H; Concannon J; Smith I; Clemons PA; Singh S; Rees P; Horvath P; Linington RG; Carpenter AE
    Nat Methods; 2017 Aug; 14(9):849-863. PubMed ID: 28858338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine learning models for drug-target interactions: current knowledge and future directions.
    D'Souza S; Prema KV; Balaji S
    Drug Discov Today; 2020 Apr; 25(4):748-756. PubMed ID: 32171918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical intelligence: New machine learning techniques for predicting clinical drug response.
    Turki T; Wang JTL
    Comput Biol Med; 2019 Apr; 107():302-322. PubMed ID: 30771879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic Image Analysis Software Tools for Exploring and Understanding Big Image Data from Cell-Based Assays.
    Smith K; Piccinini F; Balassa T; Koos K; Danka T; Azizpour H; Horvath P
    Cell Syst; 2018 Jun; 6(6):636-653. PubMed ID: 29953863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying drug tissue biodistribution by integrating high content screening with deep-learning analysis.
    Li Z; Xiao Y; Peng J; Locke D; Holmes D; Li L; Hamilton S; Cook E; Myer L; Vanderwall D; Cloutier N; Siddiqui AM; Whitehead P; Bishop R; Zhao L; Cvijic ME
    Sci Rep; 2020 Sep; 10(1):14408. PubMed ID: 32873881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges with risk mitigation in academic drug discovery: finding the best solution.
    Roy A
    Expert Opin Drug Discov; 2019 Feb; 14(2):95-100. PubMed ID: 30513005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.